Form 4 for FLNA FILANA THERAPEUTICS, INC.
Accepted 2025-09-22 00:00:00 ET · period of report 2025-09-18 · accession 0001437749-25-029586 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-09-22 | 2025-09-18+ | FLNA | Barry Richard | Pres, CEO, Dir | P - Purchase | $2.25 | +237.9K | 707.5K | +51% | +$534.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-18 | P | A | 5,400 | $2.13 | 474,962 | I By Trust | — | — | |
| 2 | Common | Common Stock | 2025-09-18 | P | A | 185,233 | $2.24 | 660,195 | I By Trust | — | — | |
| 3 | Common | Common Stock | 2025-09-19 | P | A | 400 | $2.25 | 660,595 | I By Trust | — | — | |
| 4 | Common | Common Stock | 2025-09-19 | P | A | 46,908 | $2.29 | 707,503 | I By Trust | — | — |